# IBIS: Italian Burden of Illness on Schizophrenia & Bipolar Disorder

> **NCT01392482** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 751725 (actual)

## Conditions studied

- Schizophrenia
- Bipolar Disorder

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01392482
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2012-09
- **Final completion:** 2012-09
- **Target enrollment:** 751725 (ACTUAL)
- **Last updated:** 2012-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01392482

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01392482, "IBIS: Italian Burden of Illness on Schizophrenia & Bipolar Disorder". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01392482. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*